FierceBiotech ١٣ فبراير ٢٠٢٦ Ultragenyx lays off 10% of workforce as FDA continues to stall gene therapy approval plans
FierceBiotech ١٣ فبراير ٢٠٢٦ 'When the markets opened, we were ready': Why biotech IPOs are back for 2026
FierceBiotech ١٢ فبراير ٢٠٢٦ Icon shares plummet after CRO reveals accounting investigation, pulls 2025 guidance
FierceBiotech ١٢ فبراير ٢٠٢٦ Lundbeck’s migraine prevention treatment sees ph. 2 success after trial’s earlier setback
FierceBiotech ١٢ فبراير ٢٠٢٦ BridgeBio preps approval push after dwarfism drug increases children's height in phase 3
FierceBiotech ١٢ فبراير ٢٠٢٦ Langer-backed biotech looks to end cancer recurrence with surgical revolution
FierceBiotech ١٢ فبراير ٢٠٢٦ Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval
FierceBiotech ١٢ فبراير ٢٠٢٦ Seres to lay off 30% of employees, pause lead program in latest strategic shift
FierceBiotech ١٢ فبراير ٢٠٢٦ Sanofi ousts Paul Hudson after ‘bumpy ride’, poaches Merck KGaA CEO to lead the French pharma
FierceBiotech ١٢ فبراير ٢٠٢٦ European VCs join forces to boost flagging biotech investment in the region
FierceBiotech ١٢ فبراير ٢٠٢٦ UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
FierceBiotech ١١ فبراير ٢٠٢٦ ‘The only thing that saves us is data’: Allogeneic CAR-T biotechs fight for relevance as industry moves on
FierceBiotech ١١ فبراير ٢٠٢٦ Upstream posts Tezspire-like asthma efficacy in phase 2 but falls short of best-case scenario
FierceBiotech ١١ فبراير ٢٠٢٦ Madrigal pens $4.4B deal for Ribo's preclinical siRNA programs in latest Rezdiffra MASH play
FierceBiotech ١١ فبراير ٢٠٢٦ GE HealthCare debuts tech to help hospitals remotely maintain bedside ECG stations
FierceBiotech ١١ فبراير ٢٠٢٦ Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale